Skip to main content
Clinical Trials/NCT02824588
NCT02824588
Completed
Not Applicable

Executive Control, Processing Speed and Memory Function in Long- Term Peripheral Neuropathic Pain and Fibromyalgia

Oslo University Hospital1 site in 1 country82 target enrollmentSeptember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Working Memory Deficits
Sponsor
Oslo University Hospital
Enrollment
82
Locations
1
Primary Endpoint
Objective neuropsychological tests
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The goal of this project is to investigate and improve executive control function in two distinct pain conditions, namely neuropathic pain and fibromyalgia (FM). It is hypothesized that there is a significant difference in the executive control function of patients with neuropathic pain and FM pain. It is also hypothesized that all participants with poor executive control functioning will report significant improvements in pain intensity, functioning and cognitive complaints following cognitive training. The study tests and influence the working memory concepts of inhibition, updating and flexibility through an experimental, cross-over treatment design.

To perform the experiment, we will recruit 160 participants (80 with neuropathic pain and 80 with FM) from the Departments of pain management and research at St Olav's University Hospital and Oslo University Hospital (OUS). The proposed design will be able to determine whether or not executive control, processing speed and memory function differs in two distinct populations of pain patients. Moreover, whether impairments are amended by computerized training.

Registry
clinicaltrials.gov
Start Date
September 2016
End Date
September 2, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Henrik Børsting Jacobsen

Post Doctoral Fellow

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • Confirmed diagnosis of fibromyalgia or neuropathic pain
  • Confirmed objective cognitive impairments on the CANTAB battery compared to IQ control

Exclusion Criteria

  • Mania, suicidal ideation and/or active psychosis
  • No objective cognitive impairments
  • Personality disorders
  • Pregnancy

Outcomes

Primary Outcomes

Objective neuropsychological tests

Time Frame: 36 weeks

CANTAB test battery

Secondary Outcomes

  • Sleep duration, quality and awakening(36 weeks)
  • Quality of life(36 weeks)
  • Medication use(36 weeks)
  • Stress regulation(36 weeks)
  • Self-reported memory and concentration impairments(36 weeks)
  • Pain intensity(36 weeks)
  • Symptoms of depression(36 weeks)
  • Self-reported cognitive intrusion(36 weeks)

Study Sites (1)

Loading locations...

Similar Trials